17 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18642382 | METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR | RAMACHANDRAN, UMAMAHESWARI | 1627 | Final Rejection | Apr 22, 2024 |
| 18541691 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS | VALENROD, YEVGENY | 1628 | Non-Final OA | Dec 15, 2023 |
| 18564987 | METHODS AND COMPOSITIONS FOR TRANSDUCTION OF NK CELLS | WANG, RUIXUE | 1672 | Non-Final OA | Nov 28, 2023 |
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Mar 14, 2023 |
| 18042015 | COMPOSITIONS AND METHOD FOR TREATING THALASSEMIA | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Feb 17, 2023 |
| 18041873 | Use of Amylase or Maltose to Treat or Prevent Neurodegeneration | O'NEILL, MARISOL ANN | 1633 | Final Rejection | Feb 16, 2023 |
| 18015657 | SUBSTITUTED 4-(3-AMINOPROP-1-YL)AMINOQUINOLINE ANALOGS AS MODULATORS OF MELANOMA-ASSOCIATED ANTIGEN 11 UBIQUITIN LIGASE | HERNANDEZ, JACKSON J | 1627 | Non-Final OA | Jan 11, 2023 |
| 18003093 | METHODS OF GENERATING AN ACTIVATION INDUCIBLE EXPRESSION SYSTEM IN IMMUNE CELLS | LEONARD, ARTHUR S | 1631 | Non-Final OA | Dec 22, 2022 |
| 17927038 | Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations | PYLA, EVELYN Y | 1633 | Non-Final OA | Nov 22, 2022 |
| 17918644 | CHIMERIC MYD88 RECEPTORS | SUNSHINE, HANNAH LOUISE | 1647 | Final Rejection | Oct 13, 2022 |
| 17917198 | B7-H3 CHIMERIC ANTIGEN RECEPTORS | RIGA, MICHAEL ANGELO | 1634 | Non-Final OA | Oct 05, 2022 |
| 17801907 | RECOMBINANT FIBCD1 AND USE THEROF IN THE TREATMENT OF MUSCLE ATROPHY | WHITE, ASHLEY TAYLOR | 1653 | Final Rejection | Aug 24, 2022 |
| 17636152 | SCHIZOPHRENIA-RELATED MICRODELETION GENE 2510002D24Rik IS ESSENTIAL FOR SOCIAL MEMORY | SINGH, ANOOP KUMAR | 1632 | Final Rejection | Feb 17, 2022 |
| 17631067 | GENETIC MUTATIONAL ANALYSIS | YOUNG, BRIAN ELLIS | 1684 | Final Rejection | Jan 28, 2022 |
| 17550051 | Use of FOXP3 Enhancers to Modulate Regulatory T Cells | WILSON, MICHAEL C | 1638 | Final Rejection | Dec 14, 2021 |
| 17605639 | GENE KNOCK-OUTS TO IMPROVE T CELL FUNCTION | ABBOTT, KODYE LEE | 1634 | Non-Final OA | Oct 22, 2021 |
| 17602524 | DNMT3A KNOCK-OUT STAT5 ACTIVATED GENETICALLY ENGINEERED T-CELLS | CHASE, CAROL ANN | 1646 | Non-Final OA | Oct 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial